22460-1-AP
antibody from Proteintech Group
Targeting: NR5A2
B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22460-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- NR5A2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated NR5A2 antibody (Cat. #22460-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references NR5A2 Is One of 12 Transcription Factors Predicting Prognosis in HNSCC and Regulates Cancer Cell Proliferation in a p53-Dependent Manner.
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15.
Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids.
MicroRNA-3613-5p Promotes Lung Adenocarcinoma Cell Proliferation through a RELA and AKT/MAPK Positive Feedback Loop.
Zhang K, Xiao M, Jin X, Jiang H
Frontiers in oncology 2021;11:691318
Frontiers in oncology 2021;11:691318
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15.
Guo F, Zhou Y, Guo H, Ren D, Jin X, Wu H
Cell death discovery 2021 Apr 13;7(1):78
Cell death discovery 2021 Apr 13;7(1):78
Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids.
Liu J, Li Y, Sun C, Liu S, Yan Y, Pan H, Fan M, Xue L, Nie C, Zhang H, Qian H, Ying H, Wang L
Pharmacological research 2020 Feb;152:104631
Pharmacological research 2020 Feb;152:104631
MicroRNA-3613-5p Promotes Lung Adenocarcinoma Cell Proliferation through a RELA and AKT/MAPK Positive Feedback Loop.
He T, Shen H, Wang S, Wang Y, He Z, Zhu L, Du X, Wang D, Li J, Zhong S, Huang W, Yang H
Molecular therapy. Nucleic acids 2020 Dec 4;22:572-583
Molecular therapy. Nucleic acids 2020 Dec 4;22:572-583
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- rat testis tissue were subjected to SDS PAGE followed by western blot with 22460-1-AP( NR5A2 Antibody) at dilution of 1:600
- Other comments
- WB